IL17A and hepatocellular carcinoma: When the median value (455 pg/ml) was used as the cutoff point, patients with IL-17 ≥ the median had a significantly higher cumulative incidence of HCC than those with IL-17 < the median (P = 0.008, Fig. 1a).